Healthcare

What would legalization and widespread availability of psilocybin therapy look like? Here, we connect with Dr. Sunil Aggarwal, a palliative care physician and cofounder of the Advanced Integrative Medical Science Institute (AIMS) in Seattle, Washington, to find out.

The COVID-19 vaccine, and the speed at which it was developed, is the medical breakthrough of our lifetimes.

A review on a handful of recent articles related to COVID-19 and cannabis as well as an interview with a top medical cannabis expert—Dr. Prakash Nagarkatti.

An interview with Dr. Bonni Goldstein on treating patients during a pandemic, telemedicine, cannabis research, and more.

An interview with an amazing family of four doctors—the Knox Docs—who are key opinion leaders in cannabis therapeutics, endocannabinology, and cannabinoid medicine.

A closer look at some of the current in vitro evidence suggesting that cannabinoids possess potent activity against a range of gram-positive bacteria.

GW Pharmaceuticals recently announced the company’s financial results from the second quarter of 2019.

Here we review the current and pertinent literature in utilizing cannabis derivatives in animals and discuss the future forecast of cannabis in veterinary medicine.

An interview with Sue Sisley

An interview with Montel Williams

An interview with Uma Dhanabalan

Giuseppe Cannazza and Cinzia Citti from the University of Modena and Reggio Emilia discuss the growing interest in the use of medicinal cannabis in Europe and the analytical challenges involved.

David Fulper, PhD, director of technology support at Catalent, shares insights on the challenges and opportunities for cannabis-based therapeutics.